|
⚲
|
| Keyboard |
| David Taft | |
|---|---|
| Firm | |
| Address | 266 Main Street Suite 37 Medfield, MA 02052 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Aztherapies Inc | 021-375480 | Director | 14.8 M of 35.0 M |
||
| Aztherapies Inc | 021-344167 | Director | 19.0 M of 37.5 M |
||
| Aztherapies Inc | 021-340856 | Director | 5.6 M of 7.5 M |
||
| Aztherapies Inc | 021-315997 | Director | 16.1 M of 25.5 M |
||
| Aztherapies Inc | 021-301054 | Director | 1.6 M of 6.0 M |
||
| Applied Minerals Inc | 021-294023 | Director | 0.9 M of 0.9 M |
||
| Aztherapies Inc | 021-289907 | Director | 6.5 M of 7.6 M |
||
| Aztherapies Inc | 021-252538 | Director | 16.1 M of 20.0 M |
||
| Xolve Inc | 021-215235 | Director | 0.4 M of 0.8 M |
||
| Iquum Inc | 021-152753 | Director | 1.0 M of 5.0 M |
||
| IBS Turnaround Fund L P | 021-78983 | Executive Officer | 101.8 M | ||
| Applied Minerals Inc | 021-85532 | Director | 6.0 M of 6.0 M |
||
| IBS Capital LLC | |||||
| The IBS Opportunity Fund Ltd | 021-173508 | Director | 25.7 M | 11.6 M | |
| The IBS Turnaround Fund QP A Limited Partnership | 021-138225 | Executive Officer | 247.1 M | 73.3 M | |